
|Articles|August 15, 2005
Double-digit growth seen in prescription inserts
Des Plaines, IL—Addition Technology Inc. has seen another boost in sales of its micro-thin prescription inserts (Intacs).
Advertisement
Des Plaines, IL-Addition Technology Inc. has seen another boost in sales of its micro-thin prescription inserts (Intacs).
The company said its second-quarter 2005 sales of the prescription inserts, which are used to treat keratoconus and myopia, increased 55% versus the same quarter the previous year. Sales increased 45% over the first quarter this year. The company said it is the ninth consecutive quarter for double-digit growth.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials
2
MacTel Decoded: Rethinking Conventional Approaches with Novel Neuroprotective Strategies
3
Study finds artificial tear viscosity and shear-thinning behavior vary by formulation
4
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for Demodex Blepharitis
5



























